# Raclopride-PET/MRT

> **NCT03637075** · NA · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** intranasal insulin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03637075
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-20
- **Primary completion:** 2023-06-06
- **Final completion:** 2023-12-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03637075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03637075, "Raclopride-PET/MRT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03637075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*